These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28570499)

  • 41. Cognitive Behavioral Analysis System of Psychotherapy versus Escitalopram in Chronic Major Depression.
    Schramm E; Zobel I; Schoepf D; Fangmeier T; Schnell K; Walter H; Drost S; Schmidt P; Brakemeier EL; Berger M; Normann C
    Psychother Psychosom; 2015; 84(4):227-40. PubMed ID: 26022410
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram.
    Allard P; Gram L; Timdahl K; Behnke K; Hanson M; Søgaard J
    Int J Geriatr Psychiatry; 2004 Dec; 19(12):1123-30. PubMed ID: 15526307
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Efficacy of escitalopram and severity of depression: new data].
    Spadone C
    Encephale; 2009 Dec; 35(6):577-85. PubMed ID: 20004289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. First episode of major depressive disorder and vascular factors in coronary artery disease patients: Baseline characteristics and response to antidepressant treatment in the CREATE trial.
    Habra ME; Baker B; Frasure-Smith N; Swenson JR; Koszycki D; Butler G; van Zyl LT; Lespérance F
    J Psychosom Res; 2010 Aug; 69(2):133-41. PubMed ID: 20624511
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Economic consequence of switching to citalopram after its generic entry for adult patients with major depressive disorder (MDD) treated with escitalopram: a 6-month retrospective study.
    Yu AP; Xie J; Bensimon A; Parikh K; Wu EQ; Ben-Hamadi R; Blum S; Haim Erder M
    J Med Econ; 2010; 13(4):599-609. PubMed ID: 20879834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder.
    Amsterdam JD; Shults J; Rutherford N
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):100-6. PubMed ID: 17804135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Repetitive transcranial magnetic stimulation (rTMS) in a patient suffering from comorbid depression and panic disorder following a myocardial infarction.
    Sakkas P; Psarros C; Papadimitriou GN; Theleritis CG; Soldatos CR
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):960-2. PubMed ID: 16631291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness and safety of citalopram in hospitalized adolescents with major depression: a preliminary, 8-week, fixed-dose, open-label, prospective study.
    Shoval G; Nahshoni E; Gothelf D; Manor I; Golobchik P; Zemishlany Z; Weizman A; Zalsman G
    Clin Neuropharmacol; 2011; 34(5):182-5. PubMed ID: 21926484
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder.
    Fantino B; Moore N; Verdoux H; Auray JP
    Int Clin Psychopharmacol; 2007 Mar; 22(2):107-15. PubMed ID: 17293711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Putting theory into practice: a challenging case study in the treatment of depression.
    J Fam Pract; 2003 Dec; Suppl():S63-70. PubMed ID: 14693080
    [No Abstract]   [Full Text] [Related]  

  • 51. Persistence of antidepressant treatment effects in a pharmacotherapy plus psychotherapy trial for active injection drug users.
    Stein MD; Solomon DA; Anderson BJ; Herman DS; Anthony JL; Brown RA; Ramsey SE; Miller IW
    Am J Addict; 2005; 14(4):346-57. PubMed ID: 16188715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder.
    von Knorring AL; Olsson GI; Thomsen PH; Lemming OM; Hultén A
    J Clin Psychopharmacol; 2006 Jun; 26(3):311-5. PubMed ID: 16702897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute reduction in anxiety after deep transcranial magnetic stimulation (DTMS) in unipolar major depression- a systematic review and meta-analysis.
    Kedzior KK; Gellersen HM; Roth Y; Zangen A
    Psychiatry Res; 2015 Dec; 230(3):971-4. PubMed ID: 26616303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Escitalopram for major depression in Parkinson's disease: an open-label, flexible-dosage study.
    Weintraub D; Taraborelli D; Morales KH; Duda JE; Katz IR; Stern MB
    J Neuropsychiatry Clin Neurosci; 2006; 18(3):377-83. PubMed ID: 16963587
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder.
    Langworth S; Bodlund O; Agren H
    J Clin Psychopharmacol; 2006 Apr; 26(2):121-7. PubMed ID: 16633139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thyroid autoimmunity and treatment response to escitalopram in major depression.
    Eller T; Metsküla K; Talja I; Maron E; Uibo R; Vasar V
    Nord J Psychiatry; 2010 Aug; 64(4):253-7. PubMed ID: 20088751
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Response-dependent differences in regional cerebral blood flow changes with citalopram in treatment of major depression.
    Joe AY; Tielmann T; Bucerius J; Reinhardt MJ; Palmedo H; Maier W; Biersack HJ; Zobel A
    J Nucl Med; 2006 Aug; 47(8):1319-25. PubMed ID: 16883012
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
    Howland RH; Rush AJ; Wisniewski SR; Trivedi MH; Warden D; Fava M; Davis LL; Balasubramani GK; McGrath PJ; Berman SR
    Drug Alcohol Depend; 2009 Jan; 99(1-3):248-60. PubMed ID: 18986774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in depression subtypes for women during treatment with citalopram: a latent transition analysis.
    Ulbricht CM; Dumenci L; Rothschild AJ; Lapane KL
    Arch Womens Ment Health; 2016 Oct; 19(5):769-78. PubMed ID: 26802021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced cardio-respiratory coupling after treatment with nortriptyline in contrast to S-citalopram.
    Bär KJ; Schuhmacher A; Höfels S; Schulz S; Voss A; Yeragani VK; Maier W; Zobel A
    J Affect Disord; 2010 Dec; 127(1-3):266-73. PubMed ID: 20538342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.